Manager TitleAgeSince
Chief Executive Officer 63 19/10/2022
President 61 29/03/2021
Comptroller/Controller/Auditor 66 12/08/2024
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 63 -
Director/Board Member 58 29/03/2022
Change 5-day change 1-year change 3-year change Capi.($)
+61.97%+49.35% - - 4L
-0.62%-0.10%+50.70%+114.07% 1,03100Cr
-2.30%-3.90%+39.50%+66.07% 64TCr
-0.63%-1.94%+12.26%+74.38% 46TCr
-1.03%-2.88%+71.35%+39.69% 36TCr
-0.03%-3.91%+34.28%+39.35% 33TCr
-1.58%+0.39%+17.92%+25.77% 27TCr
-2.02%-3.20%+7.60%+8.38% 25TCr
-3.38%+0.29%+44.32%+51.54% 23TCr
-1.04%-2.56%+32.88%+96.82% 18TCr
Average +5.58%-0.36%+34.53%+57.34% 41.82TCr
Weighted average by Cap. -0.21%-0.35%+38.05%+69.18%
Logo SL Therapeutics, Inc.
SL Therapeutics Inc, formerly Stem Lab Inc, is a Korea-based company principally engaged in the manufacture and sale of biopharmaceuticals. The Company is principally engaged in the development, research, manufacture and sale of biopharmaceuticals such as stem cell culture mediums, stem cell treatment as well as others.
Employees
-
  1. Stock Market
  2. Stocks
  3. A258540 Stock